Innovation for development: the key to a transformative recovery...
Chapter II
Bibliography Carracedo, S. and others (2020), “The landscape of COVID-19 clinical trials in Latin America and the Caribbean: assessment and challenges”, Pan American Journal of Public Health, vol. 44. Consoli, D. and A. Mina (2009), “An evolutionary perspective on health innovation systems”, Journal of Evolutionary Economics, vol. 19, No. 2. Consultora EMATRIS (2020), Caracterización de los emprendimientos y empresas de base científica tecnológica en Chile. Informe Final, Ministry of Science, Technology, Knowledge and Innovation/Ministry of Economic Affairs, Development and Tourism of Chile. Drucaroff, S. (2021), “Estudio para determinar la capacidad de producción de insumos y equipos críticos en la industria de la salud en Argentina y Brasil, dentro del contexto del COVID-19”, Economic Commission for Latin America and the Caribbean (ECLAC), unpublished. ECLAC (Economic Commission for Latin America and the Caribbean) (2021), Plan for self-sufficiency in health matters in Latin America and the Caribbean: lines of action and proposals (LC/TS.2021/115), Santiago. Gereffi, G., S. Frederick and P. Bamber (2019), “Diverse paths of upgrading in high-tech manufacturing: Costa Rica in the electronics and medical devices global value chains”, Transnational Corporations, vol. 26, No. 1. Gutman, G. and P. Lavarello (2018), “La emergencia de la industria biofarmacéutica argentina: política industrial y marco regulatorio durante los 2000”, Explorando el camino de la imitación creativa: la industria biofarmacéutica argentina en los 2000, P. Lavarello, G. Gutman and S. Sztulwark, Buenos Aires, Centre for Urban and Regional Studies (CEUR)/ National Council of Scientific and Technical Research (CONICET)/Editorial Libro Punto. (2016), “Política industrial en el sector biofarmacéutico en la Argentina durante los años 2000”, Economic Commission for Latin America and the Caribbean (ECLAC), unpublished. IQVIA (2019), “The Rise of Global Medical Technology” [online] https://www.iqvia.com/locations/belgium/newsroom/2019/03/ the-rise-of-global-medical-technology. Lavarello, P., G. Gutman and S. Sztulwark (2018), Explorando el camino de la imitación creativa: la industria biofarmacéutica argentina en los 2000, Buenos Aires, Centre for Urban and Regional Studies (CEUR)/National Council of Scientific and Technical Research (CONICET)/Editorial Libro Punto. Lavarello, P. and others (2021), “Imitación creativa frente a las oportunidades de la farmabiotecnología: enseñanza de experiencias nacionales de industrialización (muy) tardía”, Revista Brasileira de Inovação, vol. 19. OECD (Organization for Economic Cooperation and Development) (2018), Pharmaceutical Innovation and Access to Medicines, OECD Health Policy Studies, Paris, OECD Publishing. (2016a), Start-up Latin America 2016: Building an Innovative Future, Development Centre Studies, Paris, OECD Publishing. (2016b), Trade in Value Added (TiVA) [online database] https://stats.oecd.org/Index.aspx?DataSetCode=TIVA_2018_C4. PAHO (Pan American Health Organization) (2020), “Regulatory System Models for Small States/Markets with Limited Resources. Concept Note and Recommendations”, Ninth Conference of the Pan American Network for Drug Regulatory Harmonization (PANDRH). (San Salvador, 24 to 26 October, 2018), Washington, D.C. Sweet, C. (2021), “Innovation in a time of crisis”,Economic Commission for Latin America and the Caribbean (ECLAC), unpublished.
49
